Zobrazeno 1 - 10
of 44
pro vyhledávání: '"N. Z Musina"'
Autor:
T. S. Teptsova, T. P. Bezdenezhnyh, V. K. Fedyaeva, N. Z Musina, G. R. Hachatryan, V. V. Tarasov
Publikováno v:
Фармакоэкономика, Vol 11, Iss 3, Pp 13-22 (2018)
The aim was to develop a methodology for determining the willingness to pay threshold (WTPT) and its upper limit value within the Russian health care system.Materials and methods. WTPT was calculated based on the shadow budget price (i. e. determinin
Externí odkaz:
https://doaj.org/article/328fb7373f08455ea7b23e2dcf1ba3c1
Publikováno v:
Фармакоэкономика, Vol 16, Iss 1, Pp 17-34 (2023)
Objective: to evaluate the clinical and economic feasibility of expanding the preferential drug provision (PDP) program for adult patients at very high cardiovascular (CV) risk, including those who have not reached lipid targets on statin therapy, by
Externí odkaz:
https://doaj.org/article/aabf14958cbb41388593a6412aa331ad
Publikováno v:
FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 15:40-50
Objective: to evaluate clinical-economic feasibility and impact of follitropin alfa on the state healthcare budget of the Russian Federation in the population of women with diagnosed infertility and poor ovarian response, who undergo treatment with a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f89d1bbaf48894bfc28f973efe2b3c8
https://doi.org/10.17749/2070-4909/farmakoekonomika.2022.129
https://doi.org/10.17749/2070-4909/farmakoekonomika.2022.129
Autor:
D. G. Shchurov, N. N. Sisigina, V. K. Fedyaeva, R. V. Gostischev, O. A. Sukhorukikh, V. V. Omelyanovskiy, N. Z. Musina
Publikováno v:
Фармакоэкономика, Vol 13, Iss 4, Pp 438-451 (2021)
This article contains the aims and main principles of the concept of value-based healthcare (VBHC). The relevance of the implementation of this approach into the Russian healthcare system results from the fact that during the control and payment for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e6c412c59e7e899b5433f6ce0942344
https://www.pharmacoeconomics.ru/jour/article/view/457
https://www.pharmacoeconomics.ru/jour/article/view/457
Publikováno v:
Фармакоэкономика, Vol 13, Iss 4, Pp 367-376 (2021)
Introduction. Presently, the willingness-to-pay threshold (cost-effectiveness threshold, incremental cost-effectiveness ratio) is used as one of the decision-making criteria for reimbursement in some foreign countries with a developed system of healt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7b7a2fec70265f7d40023c56f5660c4
https://www.pharmacoeconomics.ru/jour/article/view/452
https://www.pharmacoeconomics.ru/jour/article/view/452
Publikováno v:
Russian Journal of Genetics. 56:1391-1405
Genetic predisposition is one of the main risk factors for developing breast cancer (BC) and ovarian cancer (OC). We conducted an analysis of the epidemiology of BRCA1 and BRCA2 gene mutations in the Russian population and analyzed domestic and inter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::501aecb2043fe20915789e05735b9ad0
https://doi.org/10.1134/s1022795420100075
https://doi.org/10.1134/s1022795420100075
Publikováno v:
Фармакоэкономика, Vol 13, Iss 3, Pp 262-269 (2020)
Aim. Development of a tool for the evaluation of the therapeutic value of anticancer drugs based on multi-criteria analysis of decision making.Materials and methods. The study included 4 main stages. At the first stage, based on the results of the pu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60b1d8520ba1077c1b72f7ccac78c6b9
https://www.pharmacoeconomics.ru/jour/article/view/419
https://www.pharmacoeconomics.ru/jour/article/view/419
Publikováno v:
Фармакоэкономика, Vol 13, Iss 2, Pp 170-182 (2020)
Aim. To review foreign approaches to the evaluation and financing of in vivo gene therapy drugs. Materials and Methods. The first stage of the review included the systematic search for publications of clinical-economic studies (CES) on in vivo gene t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::113cbc97841087375c3a877df73d120e
https://doi.org/10.17749/2070-4909/farmakoekonomika.2020.040
https://doi.org/10.17749/2070-4909/farmakoekonomika.2020.040
Publikováno v:
Фармакоэкономика, Vol 12, Iss 4, Pp 318-326 (2020)
Methods of payment to care providers constitute an essential part of the healthcare financing system; these mechanisms determine the motivation of service providers. Throughout the history of public health care, the payment methods have been graduall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6758dd5ba8a371725701739ad5a789d
https://doi.org/10.17749/2070-4909.2019.12.4.318-326
https://doi.org/10.17749/2070-4909.2019.12.4.318-326
Autor:
N. Z Musina, T. A Zatsepilova, Susanna S Sologova, Vadim V. Tarasov, A. S Belosludtsev, E. M Grigorevskikh, E. G Mokshanova, Svetlana A. Lebedeva, N. G Preferanskaya, E. S Zykova, Vladimir N. Chubarev, D. I. Sologova
Publikováno v:
Medical Journal of the Russian Federation. 25:127-134
This review is devoted to updating the existing knowledge about pharmacology of the drugs from the group of direct oral anticoagulants (DOACs). Special attention is paid to comparison of the anticoagulant properties of DOACs with traditional (indirec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e541e8f605c40efb8ae4b7180bcc9eb8
https://doi.org/10.18821/0869-2106-2019-25-2-127-134
https://doi.org/10.18821/0869-2106-2019-25-2-127-134